Dariusz Dudek

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

• Gogas B,
• Bourantas C,
• Garcia-Garcia H,
• Onuma Y,
• Muramatsu T,
• Farooq V,
• Diletti R,
• van Geuns R-J,
• De Bruyne B,
• Chevalier B,
• Thuesen L,
• Smits P,
• Dudek D,
• Koolen J,
• Windecker S,
• Whitbourn R,
• McClean D,
• Dorange C,
• Miquel-Hebert K,
• Veldhof S,
• Rapoza R,
• Ormiston J,
• Serruys PW

EuroIntervention 2013; 8-online publish-ahead-of-print April 2013

Published ahead of print on April 30, 2013

Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial

• Caixeta A,
• Lansky A,
• Mehran R,
• Brener S,
• Claessen B,
• Genereux P,
• Palmerini T,
• Witzenbichler B,
• Guagliumi G,
• Brodie B,
• Dudek D,
• Fahy M,
• Dangas G,
• Stone G

EuroIntervention 2013; 8-online publish-ahead-of-print March 2013

Published ahead of print on March 22, 2013

Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial

• Rakowski T,
• Dudek D,
• Dziewierz A,
• Yu J,
• Witzenbichler B,
• Guagliumi G,
• Kornowski R,
• Hartmann F,
• Lansky A,
• Brener S,
• Mehran R,
• Stone G

EuroIntervention 2013;8:1307-1314

Published in Volume 8 Number 11, March 2013

Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology

• Hamon M,
• Pristipino C,
• Di Mario C,
• Nolan J,
• Ludwig J,
• Tubaro M,
• Sabate M,
• Mauri-Ferre J,
• Huber K,
• Niemela K,
• Haude M,
• Wijns W,
• Dudek D,
• Fajadet J,
• Kiemeneij F

EuroIntervention 2013;8:1242-1251 published online ahead of print January 2013

Published in Volume 8 Number 11, March 2013

From pharmacologically assisted early transfer to a universal primary angioplasty service: the experience of the Małopolska region

• Dudek D,
• Siudak Z,
• Dziewierz A,
• Rakowski T

EuroIntervention 2012;8:P51-P54

Published in Volume 8 Supplement P, August 2012

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

• De Luca G,
• Gibson C,
• Huber K,
• Dudek D,
• Cutlip D,
• Zeymer U,
• Gyöngyösi M,
• Bellandi F,
• Noc M,
• Arntz H-R,
• Maioli M,
• Secco G,
• Zorman S,
• Gabriel H,
• Emre A,
• Rakowski T,
• van’t Hof A

EuroIntervention 2012;8:470-476

Published in Volume 8 Number 4, August 2012

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study

• Gomez-Lara J,
• Diletti R,
• Brugaletta S,
• Onuma Y,
• Farooq V,
• Thuesen L,
• McClean D,
• Koolen J,
• Ormiston J,
• Windecker S,
• Whitbourn R,
• Dudek D,
• Dorange C,
• Veldhof S,
• Rapoza R,
• Regar E,
• García-García HM,
• Serruys PW

EuroIntervention 2012;8:214-224

Published in Volume 8 Number 2, June 2012

Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

• Dudek D,
• Onuma Y,
• Ormiston J,
• Thuesen L,
• Miquel-Hebert K,
• Serruys PW

EuroIntervention 2012;7:1060-1061 publish onlinea ahead of print September 2011

Published in Volume 7 Number 9, January 2012

Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial

• Généreux P,
• Mehran R,
• Palmerini T,
• Caixeta A,
• Kirtane A,
• Lansky A,
• Brodie B,
• Witzenbichler B,
• Mockel M,
• Guagliumi G,
• Peruga J,
• Dudek D,
• Fahy M,
• Dangas G,
• Stone G

EuroIntervention 2011;7:905-916

Published in Volume 7 Number 8, December 2011

A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque

• Brugaletta S,
• Serruys PW,
• Ormiston J,
• Gomez-Lara J,
• Farooq V,
• van Geuns R-J,
• de Bruyne B,
• Dudek D,
• Thuesen L,
• Chevalier B,
• McClean D,
• Windecker S,
• Whitbourn R,
• Veldhof S,
• Miquel-Hebert K,
• Rapoza R,
• van Domburg R,
• Sihan K,
• de Winter S,
• García-García HM,
• Bruining N

Published in Volume 7 Supplement M, May 2011

Is angiography enough for optimal stenting of the culprit lesion in patients with acute myocardial infarction (STEMI and NSTEMI)? An intravascular ultrasound and virtual histology (intravascular ultrasound-VH) study

• Jakala J,
• Legutko J,
• Wizimirski M,
• Rzeszutko L,
• Partyka L,
• Mrevlje B,
• Richter A,
• Margolis P,
• Kaluza G,
• Dudek D

Published in Volume 7 Supplement M, May 2011

One-year follow-up of the ProNOVA XR polymer free Sirolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the EURONOVA study

• Legutko J,
• Heba G,
• Rzeszutko L,
• Zasada W,
• Jakala J,
• Dragan J,
• Klecha A,
• Giszterowicz D,
• Dobrowolski W,
• Partyka L,
• Dudek D

Published in Volume 7 Supplement M, May 2011

Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-up

• Gomez-Lara J,
• Brugaletta S,
• Farooq V,
• van Geuns R-J,
• de Bruyne B,
• Windecker S,
• McClean D,
• Thuesen L,
• Dudek D,
• Koolen J,
• Whitbourn R,
• Smits P,
• Chevalier B,
• Morel M-A,
• Dorange C,
• Veldhof S,
• Rapoza R,
• García-García HM,
• Ormiston J

Published in Volume 7 Supplement M, May 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

• Brugaletta S,
• García-García HM,
• Diletti R,
• Gomez-Lara J,
• Garg S,
• Onuma Y,
• Shin E,
• van Geuns R-J,
• de Bruyne B,
• Dudek D,
• Thuesen L,
• Chevalier B,
• McClean D,
• Windecker S,
• Whitbourn R,
• Dorange C,
• Veldhof S,
• Rapoza R,
• Sudhir K,
• Bruining N,
• Ormiston J,
• Serruys PW

EuroIntervention 2011;6:1110-1116

Published in Volume 6 Number 9, April 2011

Tools & Techniques: PCI for acute MI tips and tricks

• Dudek D,
• Dziewierz A,
• Mielecki W

EuroIntervention 2011;6:900-901

Published in Volume 6 Number 7, February 2011

Mesh covered stent in ST-segment elevation myocardial infarction

• Dudek D,
• Dziewierz A,
• Rzeszutko L,
• Legutko J,
• Dobrowolski W,
• Rakowski T,
• Bartus S,
• Dragan J,
• Klecha A,
• Lansky A,
• Siudak Z,
• Zmudka K

EuroIntervention 2010;6:582-589

Published in Volume 6 Number 5, November 2010

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

• Onuma Y,
• Serruys PW,
• Ormiston J,
• Regar E,
• Webster M,
• Thuesen L,
• Dudek D,
• Veldhof S,
• Rapoza R

EuroIntervention 2010;6:447-453 published online ahead of print June 2010

Published in Volume 6 Number 4, September 2010

Peripheral percutaneous interventions in cardiac patients performed by interventional cardiologists: rationale, results and long term follow-up

• Bartus S,
• Brzezinski M,
• Siudak Z,
• Rakowski T,
• Chyrchel M,
• Dziewierz A,
• Dubiel J,
• Dudek D

Published in Volume 6 Supplement H, May 2010

Impact of multivessel coronary artery disease and non-infarct related artery revascularisation on outcome of patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention

• Dziewierz A,
• Siudak Z,
• Rakowski T,
• Mielecki W,
• Dubiel J,
• Dudek D

Published in Volume 6 Supplement H, May 2010

Multicentre, first-in-man study on the Elixir Myolimus-eluting coronary stent system with bioabsorbable polymer: 12-month clinical and angiographic/IVUS results

• Schofer J,
• Dudek D,
• Witzenbichler B,
• Lesiak M,
• Hauptmann K-E,
• Meredith L,
• Bhat V,
• Yan J,
• Otake H,
• Nakatani D

Published in Volume 6 Supplement H, May 2010

Conformability of bioresorbable Everolimus-eluting scaffolds as compared to metal platform stents

• Gomez-Lara J,
• García-García HM,
• Onuma Y,
• Thuesen L,
• Dudek D,
• Garg S,
• de Bruyne B,
• Windecker S,
• Chevalier B,
• Smits P,
• McClean DR,
• Koolen J,
• Whitbourn R,
• Veldhof S,
• Dorange C,
• Ormiston J,
• Serruys PW

Published in Volume 6 Supplement H, May 2010

Long term clinical outcome after thrombectomy or standard angioplasty in patients with ST elevation myocardial infarction: individual patient data pooled analysis of 11 randomised trials

• De Vita M,
• Burzotta F,
• Gu Y,
• Isshiki T,
• Lefèvre T,
• Kaltoft A,
• Dudek D,
• Sardella G,
• Silva-Orrego P,
• Antoniucci D,
• De Luca L,
• Biondi-Zoccai G,
• Crea F,
• Zijlstra F

Published in Volume 5 Supplement E, May 2009

Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.

• García-García HM,
• Gonzalo N,
• Pawar R,
• Kukreja N,
• Dudek D,
• Thuesen L,
• Ormiston J,
• Regar E,
• Serruys PW

EuroInterv.2009;4:443-448

Published in Volume 4 Number 4, January 2009

European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club

• Di Mario C,
• Werner G,
• Sianos G,
• Galassi A,
• Büttner J,
• Dudek D,
• Chevalier B,
• Lefèvre T,
• Schofer J,
• Koolen J,
• Sievert H,
• Reimers B,
• Fajadet J,
• Colombo A,
• Gershlick A,
• Serruys PW,
• Reifart N

EuroInterv.2007;3:30-43

Published in Volume 3 Number 1, May 2007

N-terminal pro-brain natriuretic peptide level in relation to epicardial and myocardial reperfusion in ST-segment elevation myocardial infarction treated with facilitated angioplasty

• Zmudka K,
• Zalewski J,
• El Masri N,
• Stepien E,
• Zajdel W,
• Durak M,
• Dudek D,
• Przewlocki. T

EuroInterv.2006;2:203-210

Published in Volume 2 Number 2, August 2006

Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable angina

• Dudek D,
• Heba G,
• Legutko J,
• Chyrchel M,
• Rakowski T,
• Kaluza G,
• Dubiel J

EuroInterv.2005;1:315-320

Published in Volume 1 Number 3, November 2005

Time-to-reperfusion therapy influences outcome of patients with myocardial infarction subjected to facilitated PCI

• Dudek D,
• Dziewierz A,
• Rakowski T,
• El Masri N,
• Sorysz D,
• Zalewski J,
• Legutko J,
• Zmudka K,
• Piwowarska W,
• Dubiel J

EuroInterv.2005;1:309-314

Published in Volume 1 Number 3, November 2005